These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25044355)

  • 21. Non-alcoholic fatty liver disease and its associated risk factors in Brazilian postmenopausal women.
    Bruno Ade S; Rodrigues MH; Alvares MC; Nahas-Neto J; Nahas EA
    Climacteric; 2014 Aug; 17(4):465-71. PubMed ID: 24517420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overweight, obesity and weight gain up to three years after liver transplantation.
    Rezende Anastácio L; García Ferreira L; Costa Liboredo J; de Sena Ribeiro H; Soares Lima A; García Vilela E; Correia MI
    Nutr Hosp; 2012; 27(4):1351-6. PubMed ID: 23165585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevalence of nonalcoholic fatty liver disease and metabolic abnormalities in 387 obese children and adolescents in Beijing, China].
    Zhou X; Hou DQ; Duan JL; Sun Y; Cheng H; Zhao XY; Liu JT; Yang P; Shan XY; Mi J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 May; 34(5):446-50. PubMed ID: 24016432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction.
    Adams LA; Feldstein A; Lindor KD; Angulo P
    Hepatology; 2004 Apr; 39(4):909-14. PubMed ID: 15057893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
    Guo M; Xi G; Yang N; Yao H
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Body mass index in school-aged children and the risk of routinely diagnosed non-alcoholic fatty liver disease in adulthood: a prospective study based on the Copenhagen School Health Records Register.
    Zimmermann E; Gamborg M; Holst C; Baker JL; Sørensen TI; Berentzen TL
    BMJ Open; 2015 May; 5(4):e006998. PubMed ID: 25941179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant Management.
    Siddiqui MS; Charlton M
    Gastroenterology; 2016 Jun; 150(8):1849-62. PubMed ID: 26971826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience.
    Heuer M; Kaiser GM; Kahraman A; Banysch M; Saner FH; Mathé Z; Gerken G; Paul A; Canbay A; Treckmann JW
    Digestion; 2012; 86(2):107-13. PubMed ID: 22846254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonalcoholic Fatty Liver Disease and Liver Transplantation.
    Pham T; Dick TB; Charlton MR
    Clin Liver Dis; 2016 May; 20(2):403-17. PubMed ID: 27063277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study.
    Lee MJ; Kim EH; Bae SJ; Kim GA; Park SW; Choe J; Jung CH; Lee WJ; Kim HK
    Gut Liver; 2019 Jan; 13(1):67-76. PubMed ID: 30037166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural history and predictors of obesity after orthotopic heart transplantation.
    Baker AM; Levine TB; Goldberg AD; Levine AB
    J Heart Lung Transplant; 1992; 11(6):1156-9. PubMed ID: 1457440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High body mass index and posttransplant weight gain are not risk factors for kidney graft and patient outcome.
    Marcén R; Fernández A; Pascual J; Teruel JL; Villafruela JJ; Rodriguez N; Martins J; Burgos FJ; Ortuño J
    Transplant Proc; 2007 Sep; 39(7):2205-7. PubMed ID: 17889138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD.
    Önnerhag K; Nilsson PM; Lindgren S
    Scand J Gastroenterol; 2014 Sep; 49(9):1111-8. PubMed ID: 24990583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment].
    Koga M
    Seishin Shinkeigaku Zasshi; 2003; 105(4):473-88. PubMed ID: 12806910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
    Contos MJ; Cales W; Sterling RK; Luketic VA; Shiffman ML; Mills AS; Fisher RA; Ham J; Sanyal AJ
    Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-alcoholic fatty liver disease incidence, remission and risk factors among a general Chinese population with a 6-year follow-up.
    Wu J; He S; Xu H; Chi X; Sun J; Wang X; Gao X; Wu R; Shao M; Zhao H; Jia J; Wang C; Niu J
    Sci Rep; 2018 May; 8(1):7557. PubMed ID: 29765064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation.
    Mindikoglu AL; Regev A; Casanova-Romero PY; Bejarano PA; Martinez EJ; Tzakis AG; Schiff ER
    Transplant Proc; 2006 Jun; 38(5):1440-4. PubMed ID: 16797327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.
    Kodhelaj K; Resuli B; Petrela E; Malaj V; Jaze H
    Minerva Pediatr; 2014 Feb; 66(1):23-30. PubMed ID: 24608579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Body Weight Gain on the Incidence of Nonalcoholic Fatty Liver Disease in Nonobese Japanese Individuals.
    Yamada G; Hagiwara Y; Kimura T; Takeuchi Y; Oba K; Masuda K; Matsuyama Y
    Am J Gastroenterol; 2021 Apr; 116(4):733-740. PubMed ID: 33982943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.